What exactly did Meiji Yasuda Life disclose?

The company said five secondees removed 39 internal documents from four insurance agencies between 2021 and 2025. The case raises questions about data handling and potential competition issues. It has put governance and compliance at the center of the discussion for Japan life insurers and their agency networks.

How could antitrust scrutiny affect Japan life insurers?

If authorities deepen reviews, insurers may face higher compliance costs, tighter data controls, and possible changes to how information flows across agency channels. Short term, this could slow sales execution. Longer term, stronger guardrails can reduce legal risk and stabilize relationships with insurance agents and customers.

How did 8750.T trade today and what are key levels?

Dai‑ichi Life closed at ¥1,329, down 1.77%, with a ¥1,301–¥1,329 range. The upper Bollinger band sits near ¥1,374 and the 50‑day average near ¥1,289. RSI is 67.6. We watch reactions around ¥1,300 support and momentum near the 52‑week high of ¥1,421.

What should investors watch into Dai‑ichi’s earnings?

Focus on management’s comments about agency oversight, compliance spending, and any impact on sales and margins. Track new business value, solvency margin, lapse trends, and capital return plans. Clear guidance can determine whether headline risk is a short-lived sentiment issue or a cost headwind to model.

Is the stock expensive after the recent rally?

At about 12x earnings and 1.26x book with a 3.23% yield, valuation looks reasonable. The key debate is whether stronger controls will nudge SG&A higher. If growth and returns hold, the multiple appears defensible. We would reassess if earnings guidance weakens.

Global Market Insights

8750.T Stock Today: January 28 Meiji Yasuda Leak Puts Insurers on Watch

ByDanny Kontos January 28, 2026

Meiji Yasuda Life has confirmed that five secondees removed 39 internal documents from four insurance agencies between 2021 and 2025. The news spotlights compliance and potential antitrust scrutiny across Japan life insurers. Investors are focusing on agency-channel controls, cost risks, and any ripple effects for listed peers. Dai‑ichi Life (8750.T) is under the microscope ahead of earnings as markets weigh governance signals against fundamentals. We break down the headlines, price action, valuations, and the key watch items for the coming weeks in Tokyo.